|
Government Exhibit P3299
Key Business Profile and Logistics
Survey Summary Johnson & Johnson is one of the world's largest, most diversified health care product makers. The company operates in three sectors: consumer products (Tylenol and Motrin analgesics, Reach toothbrushes, Band-Aid bandages); medical devices and diagnostics (ACUVUE contact lenses, surgical instruments, joint replacements); and pharmaceuticals (anemia drug Procrit, epilepsy medication Topamax, and Ortho-Novum oral contraceptives). Johnson & Johnson expands its product line by acquinng or partnering with smaller firms that develop new technologies. Mr. Chuck Wyckoff, vice president atlas project, indicated that the company has not evaluated EHS and has no plans to evaluate it in the near future. Mr. Wyckoff explained that the firm had purchased R/3, BW and CRM and is currently in the process of rolling them out. In January 2004, the company plans to implement BW and then R/3. In July 2004, it plans to implement CRM. Mr. Wyckoff stated that the company is in the configuration process now and has no plans to conduct any further evaluations at this time. The assistant to Mr Larry Pickering, vice president, corporate development, contacted SAP on behalf of Mr. Pickering, and confirmed that the company has not recently evaluated EHS. Contact List
North America Win/Loss data is SAP confidential, proprietary and/or trade secret information intended for SAP internal use only. Disclosure and protection of this type of information is governed by SAP's employee Confidentiality Agreement and any unauthorized disclosure will be deemed a violation thereof. North America Win/Loss reports may not be distributed externally without the recipient's signature on non-disclosure agreements or prior SAP executive management approval. As Win/Loss information is highly confidential, internal distribution of Win/Loss data is restricted and the posting of data in electronic forms must receive prior written approval by the North America Win/Loss Program Management. Prepared by Impole Corporation 3/28/03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
